Security key
05370A108
Atrium Therapeutics, Inc. - Common Stock (RNAM)
CUSIP: 05370A108
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 150,858,761
- Total 13F shares
- 82,383,646
- Share change
- +6,546,328
- Total reported value
- $913,636,020
- Put/Call ratio
- 695%
- Price per share
- $11.09
- Number of holders
- 140
- Value change
- +$45,839,329
- Number of buys
- 87
- Number of sells
- 52
Report period
Q2 2023
Institutions
140
Top holders
10
Broader feeds
Reporting periods
Holder history for CUSIP 05370A108
Recent filing periods:
Top shareholders of RNAM - Atrium Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Atrium Therapeutics, Inc. - Common Stock (RNAM) as of Q2 2023
As of 30 Jun 2023,
Atrium Therapeutics, Inc. - Common Stock (RNAM) was held by
140 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
82,383,646 shares.
The largest 10 holders included
FMR LLC, RTW INVESTMENTS, LP, PRICE T ROWE ASSOCIATES INC /MD/, RA CAPITAL MANAGEMENT, L.P., STATE STREET CORP, BlackRock Inc., COWEN AND COMPANY, LLC, VANGUARD GROUP INC, Cormorant Asset Management, LP, and Avoro Capital Advisors LLC.
This page lists
140
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
138
Q2 2023 holders
140
Holder diff
2
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.